Validation of Smart Garments for Gait Classification

October 5, 2026 updated by: Myant Medical Corp.

Validation of Smart Garments for Gait and Balance Assessment

The aim of this study is therefore to validate Myant SKIIN garments for the purpose of gait and balance assessment. To achieve this, we recruit young healthy adults from the University of Waterloo to wear Skiin products (see Fig. 1). Participants will be asked to perform a number of scripted gait and balance tasks.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Specific objectives of this study are:

  1. To validate Skiin gait characterization algorithm (based on single garment solutions - already developed based on a literature and a previous study conducted at the University of Waterloo);
  2. To develop algorithms for multi-garments solutions that aim to extract additional kinematic parameters such as joint angles.

Gait metrics from Skiin garments will be compared to metrics from a gold standard measurement (Vicon motion capture) to indicate accuracy, precision and reliability.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Waterloo, Ontario, Canada, N2L3G1
        • University of Waterloo - Engineering 7

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

A convenience-sample of 20 healthy individuals will be recruited for this study.

Description

Inclusion Criteria:

- Healthy male and female adults aged 18y - 64y old

Exclusion Criteria:

- Self-reported lower limb conditions, neurological disorders, history of concussion/brain trauma, and/or condition limiting exercise is to mitigate additional risk for injury and/or adverse reactions associated with exercise.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Healthy individuals

Gait study protocol
Device: Skiin garment and pods

Participants will be asked to wear a Skiin smart garment over their own clothes.

Small motion capture markers will be placed on their body and pressure-sensitive insoles placed into their shoes to measure the pressure underneath their feet during the study tasks.

Once the sensors are ready for collection, participants will be asked to complete 5 tasks associated with their daily activities: 1. Locomotion; 2. Lower limb strength - repeated sit-to-stand-to-sit transitions; 3. Lower limb strength and locomotion - Timed Up and Go; 4. Free walking during a 2min walk; 5. Standing balance, postural control.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Error in step length metric
Time Frame: Collection during the single study session of 1.5 hours.

The difference between step lengths calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in stride length metric
Time Frame: Collection during the single study session of 1.5 hours.

The difference between stride length calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in cadence metric
Time Frame: Collection during the single study session of 1.5 hours.

The difference between cadence calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in step duration (s) metric, and its asymmetry
Time Frame: Collection during the single study session of 1.5 hours.

The difference between step duration (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in stride duration (s) metric, and its asymmetry
Time Frame: Collection during the single study session of 1.5 hours.

The difference between stride duration (s), and its asymmetry calculated from Skiin data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in stance duration (s) metric, and its asymmetry
Time Frame: Collection during the single study session of 1.5 hours.

The difference between stance duration (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in swing duration (s) metric, and its asymmetry
Time Frame: Collection during the single study session of 1.5 hours.

The difference between swing duration(s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in initial double support (s) metric, and its asymmetry
Time Frame: Collection during the single study session of 1.5 hours.

The difference between double support (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in terminal double support (s) metric, and its asymmetry
Time Frame: Collection during the single study session of 1.5 hours.

The difference between terminal double support (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in double support (s) metric, and its asymmetry
Time Frame: Collection during the single study session of 1.5 hours.

The difference between double support (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in single limb support (s) metric, and its asymmetry
Time Frame: Collection during the single study session of 1.5 hours.

The difference between single limb support (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in gait speed metric
Time Frame: Collection during the single study session of 1.5 hours.

The difference between gait speed calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in stride speed metric
Time Frame: Collection during the single study session of 1.5 hours.

The difference between stride speed calculated from Skiin data and from Vicon data for each scripted gait tasks.
Collection during the single study session of 1.5 hours.
Error in mean CoM sway distance
Time Frame: Collection during the single study session of 1.5 hours.

The difference between sway distance of the Center of mass calculated from Skiin data and from Vicon data for each scripted balance tasks.
Collection during the single study session of 1.5 hours.
Error in mean CoM sway velocity
Time Frame: Collection during the single study session of 1.5 hours.

The difference between sway velocity of the Center of mass calculated from Skiin data and from Vicon data for each scripted balance tasks.
Collection during the single study session of 1.5 hours.
Error in CoM sway area
Time Frame: Collection during the single study session of 1.5 hours.

The difference between sway area of the Center of mass calculated from Skiin data and from Vicon data for each scripted balance tasks.
Collection during the single study session of 1.5 hours.
Error in CoM sway frequency
Time Frame: Collection during the single study session of 1.5 hours.

The difference between sway frequency of the Center of mass calculated from Skiin data and from Vicon data for each scripted balance tasks.
Collection during the single study session of 1.5 hours.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Myant Medical Corp.

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
University of Waterloo

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: James Tung, PhD, University of Waterloo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 26, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 18, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 14, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 1, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 1, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 12, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 6, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 5, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Myant/Waterloo/42689

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings